Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.
about
Cognitive and neuroplasticity mechanisms by which congenital or early blindness may confer a protective effect against schizophrenia.Treatment of advanced Parkinson's diseaseProfile of cognitive impairment in Parkinson's diseaseConsultation-liaison Approach for the Management of Psychiatric Manifestations in Parkinson's Disease and Related Disorders: A Report from Neuropsychiatric Hospital, India.Transcranial near-infrared laser therapy applied to promote clinical recovery in acute and chronic neurodegenerative diseases.The clinical symptoms of Parkinson's disease.Cerebral correlates of psychotic syndromes in neurodegenerative diseasesThe primate thalamostriatal systems: Anatomical organization, functional roles and possible involvement in Parkinson's disease.Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice.Memory Similarities Between Essential Tremor and Parkinson's Disease: A Final Common Pathway?Aging-related episodic memory decline: are emotions the key?Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.Current approaches to the treatment of Parkinson's diseaseStress-Induced Executive Dysfunction in GDNF-Deficient Mice, A Mouse Model of Parkinsonism.Cognitive Impairment Associated with Parkinson's Disease: Role of Mitochondria.Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson's disease.P300 Wave Changes in Patients with Parkinson's Disease.Neurotransmission in Parkinson's disease: beyond dopamine.Discriminating cognitive status in Parkinson's disease through functional connectomics and machine learning.Rivastigmine as a Symptomatic Treatment for Apathy in Parkinson's Dementia Complex: New Aspects for This Riddle.Clinicopathological correlates of behavioral and psychological symptoms of dementia.Perspectives on episodic-like and episodic memory.Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease.Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists.Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management.A commentary on: "A 12-year population-based study of freezing of gait in Parkinson's disease".The neural correlates of spatial and object working memory in elderly and Parkinson's disease subjects.Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.Managing psychosis in Parkinson's disease without drugs.Cognitive correlates of psychosis in patients with Parkinson's disease.The effect of interference on temporal order memory in individuals with Parkinson's disease.Pimavanserin, a novel antipsychotic for management of Parkinson's disease psychosis.The FBXO7 homologue nutcracker and binding partner PI31 in Drosophila melanogaster models of Parkinson's disease.Visual misperceptions and hallucinations in Parkinson's disease: dysfunction of attentional control networks?Strategies to maintain quality of life among people with Parkinson's disease: what works?Clinicotherapeutic Potential of Leptin in Alzheimer’s Disease and Parkinson’s Disease
P2860
Q30458900-C9552875-5649-47B8-92A7-A00B1BD10588Q30476968-C294116B-1397-455B-AAE7-160CD63DF36EQ30498333-99299C3F-B857-4A1B-B08A-DF377316EFC6Q33652329-E124A8F1-A3D6-4DEB-AE4A-EF0A9AD1BB4CQ34092740-14467CF2-04FE-4EB8-955A-B06D949F685FQ34533843-5A9622D9-5096-4BDF-854B-F6EBD7B14E36Q35194993-0E5B411E-A245-4149-BF5C-5BC9A1FBE825Q36076443-8E493543-E009-4599-AB2F-87623E5AA44BQ36486037-FBF31420-D7DD-47EB-B124-7FAAFEF7303EQ36535822-A2716C59-13CA-443E-8F63-EF2DA74901B1Q36579777-A6951CF6-17BE-4194-B039-77F6D25ABB2AQ36834550-B347D1FC-7BC5-4F08-A511-E10255E79A43Q36876438-FA08C165-76E0-449A-BA3A-DEAD59E54773Q37023040-0CE82BBF-1634-489F-8B1D-0E525FC87441Q37168743-DD165159-D21B-49C7-AB6F-F66E4CCCC51FQ37395632-44A33127-8F8B-431C-A479-19982C382E22Q37625024-F55F61BE-BCBB-4C68-B236-0AFC3A0D29BBQ37668684-6F9C2517-7DCA-415C-8D3B-01756BB83F31Q37723968-200C8B3C-9360-4A42-9A85-F9E6FFA828C5Q37733592-42FF05BC-F3CA-45F3-A8D7-611BCCB3F897Q37860194-41095D1F-A457-49D7-841E-8395B0A1843AQ38101555-6F6D2585-A3E1-48D3-BFEC-F83FC718AE4DQ38111335-F97DF3BB-A512-463C-97DF-7E1AAB51971AQ38894971-4914EB6A-7B1C-4492-AFEC-2764C501407BQ39004255-2108264F-2D7C-4C30-AEF3-D607169F94A3Q41515796-6AE8B522-1243-4C72-AE7B-754A9F2E8FE4Q42673887-35911C51-1D32-42DE-A809-6FE41D6FD93AQ42873901-458CD3C4-A6DB-445A-BC99-8EB8B84D581AQ45304644-B8C3DEB5-E069-4DB4-9BD0-7E63831E0B93Q45768490-ACF6B26E-E0AF-45C5-8A35-5F0055ABB0DFQ46687768-00E52F09-1761-4F30-86AE-150014750BA1Q47794742-41F43522-4CAA-4DBA-96B6-4897DD55FBBBQ48400507-F124009B-917A-4A66-8D76-2AD05780EEE3Q48875242-2961329B-8126-4ACD-A8F6-4F3DDC949D26Q49064482-50BC6A5A-A2CE-4625-9C13-794AA8FA390FQ59048785-D52A9C17-7CD1-4288-A96C-78897A733163
P2860
Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Cognitive deficits and psychos ...... ology and therapeutic options.
@ast
Cognitive deficits and psychos ...... ology and therapeutic options.
@en
type
label
Cognitive deficits and psychos ...... ology and therapeutic options.
@ast
Cognitive deficits and psychos ...... ology and therapeutic options.
@en
prefLabel
Cognitive deficits and psychos ...... ology and therapeutic options.
@ast
Cognitive deficits and psychos ...... ology and therapeutic options.
@en
P2860
P50
P921
P1433
P1476
Cognitive deficits and psychos ...... ology and therapeutic options.
@en
P2093
Caroline H Williams-Gray
P2860
P304
P356
10.2165/00023210-200620060-00004
P577
2006-01-01T00:00:00Z
P6179
1038366968